BioCentury
ARTICLE | Company News

Prescient, Metabiomics partner for colon cancer diagnostics

September 21, 2018 4:35 PM UTC

Prescient Medicine Holdings LLC (Hummelstown, Pa.) and Metabiomics Corp. (Aurora, Colo.) formed a JV to develop and commercialize Metabiomics' microbiome diagnostics platform to detect precancerous colon polyps and diagnose other types of gastrointestinal diseases, including Crohn's disease, colitis and irritable bowel syndrome. The partners expect the tests to be available to healthcare practitioners in 2020...